08 Sep 2026

CRC Research Update — September 08, 2026

Creator: The CRC Digest
Published: 2026-09-08T11:28:51Z

Today's colorectal cancer research highlights

1 min read

Was this forwarded to you? Read on the web or subscribe free

IMPORTANT: The CRC Digest curates and summarizes publicly available research for informational and educational purposes only. Nothing in this newsletter constitutes medical advice, diagnosis, or treatment recommendation. The information provided should not be used as a substitute for professional medical advice. Always seek the guidance of your physician or other qualified health provider with any questions regarding a medical condition or treatment. Content is generated with AI assistance and reviewed by the editorial team. We are not medical professionals. Individual results, treatments, and outcomes vary.

Signal Key

TRIAL DATA clinical trial results, efficacy data, survival endpoints TREATMENT new treatment options, regimen changes, combination therapies REGULATORY FDA/EMA approvals, guideline updates, NCCN/ESMO changes RESEARCH cancer biology, biomarker discoveries, resistance pathways SCREENING screening, colonoscopy guidelines, liquid biopsy, molecular profiling LIVING WITH CRC survivorship, quality of life, side effects, patient decision-making, caregiver support

CRC Research Update

RESEARCH
Three Distinct Activity Profiles Identified in CRC Survivors Shortly After Treatment
Accelerometer data from 358 colorectal cancer patients revealed three activity profiles: most sedentary (16%), average (53%), and highly active (31%). (J Cancer Surviv)
SCREENING
Machine Learning Model Combines FIT with Clinical Data to Triage Fast-Track Colonoscopy Referrals
Swedish researchers developed and externally validated risk models combining faecal immunochemical test results with age, sex, symptoms, and imaging to prioritize 2,539 fast-track colonoscopies, aiming to improve endoscopy capacity. (BMC Med Inform Decis Mak)
TREATMENT
Single-Institution Experience with Cytoreductive Surgery and HIPEC for Colorectal Peritoneal Metastases
Retrospective study (2009–2024) evaluated cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with colorectal peritoneal metastases. (Radiol Oncol)
REGULATORY
Chinese Expert Consensus Establishes Evaluation Standards for AI in Colorectal Cancer
(Zhonghua Wei Chang Wai Ke Za Zhi)
RESEARCH
Meta-Analysis Links Metabolic Liver Disease to Early-Onset Advanced Colorectal Neoplasia
Systematic review and meta-analysis of cohort studies quantified the association between metabolic dysfunction-associated steatotic liver disease and early-onset advanced colorectal neoplasia, informing risk stratification. (J Gastrointest Oncol)

🔬 Under 50 Spotlight

Research relevant to early-onset and younger CRC patients

Metabolic Liver Disease Associated with Early-Onset Advanced Colorectal Neoplasia
Meta-analysis of cohort studies found an association between metabolic dysfunction-associated steatotic liver disease and early-onset advanced colorectal neoplasia. (J Gastrointest Oncol)

💙 Living with CRC

Survivorship, quality of life, and supportive care

Focus Groups Identify Screening Barriers in Baltimore and Rural Maryland Communities
Qualitative study with 24 adults from Baltimore City and Maryland Eastern Shore found significant differences in screening barriers between urban and rural underserved populations. (J Cancer Educ)

This week's research spans screening triage tools, treatment approaches for advanced disease, and quality-of-life patterns in survivors.

Get CRC research intelligence delivered weekly — free.

Browse by Topic

KRAS Mutations Immunotherapy (MSI-H)BRAF Early-Onset / Under 50 Liver Metastases Clinical Trials Living with CRC All Issues

CRC Research Update

Subscribe to The CRC Digest